EP3189161A4 - Methods for diagnosis, prognosis and methods of treatment - Google Patents

Methods for diagnosis, prognosis and methods of treatment Download PDF

Info

Publication number
EP3189161A4
EP3189161A4 EP15838003.0A EP15838003A EP3189161A4 EP 3189161 A4 EP3189161 A4 EP 3189161A4 EP 15838003 A EP15838003 A EP 15838003A EP 3189161 A4 EP3189161 A4 EP 3189161A4
Authority
EP
European Patent Office
Prior art keywords
methods
prognosis
diagnosis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15838003.0A
Other languages
German (de)
French (fr)
Other versions
EP3189161A1 (en
Inventor
Alessandra Cesano
Rachael HAWTIN
Santosh Putta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nodality Inc
Original Assignee
Nodality Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nodality Inc filed Critical Nodality Inc
Publication of EP3189161A1 publication Critical patent/EP3189161A1/en
Publication of EP3189161A4 publication Critical patent/EP3189161A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP15838003.0A 2014-09-02 2015-09-02 Methods for diagnosis, prognosis and methods of treatment Withdrawn EP3189161A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462044995P 2014-09-02 2014-09-02
PCT/US2015/048184 WO2016036878A1 (en) 2014-09-02 2015-09-02 Methods for diagnosis, prognosis and methods of treatment

Publications (2)

Publication Number Publication Date
EP3189161A1 EP3189161A1 (en) 2017-07-12
EP3189161A4 true EP3189161A4 (en) 2018-06-20

Family

ID=55440349

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15838003.0A Withdrawn EP3189161A4 (en) 2014-09-02 2015-09-02 Methods for diagnosis, prognosis and methods of treatment

Country Status (2)

Country Link
EP (1) EP3189161A4 (en)
WO (1) WO2016036878A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010006291A1 (en) * 2008-07-10 2010-01-14 Nodality, Inc. Methods for diagnosis, prognosis and treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1874471A4 (en) * 2005-03-16 2008-12-10 Sidney Kimmel Cancer Ct Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures
US20140199273A1 (en) * 2011-08-05 2014-07-17 Nodality, Inc. Methods for diagnosis, prognosis and methods of treatment
US20130123131A1 (en) * 2011-11-09 2013-05-16 Nodality, Inc. Process for Ensuring Consistency and Reproducibility of a Diagnostic or Research Method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010006291A1 (en) * 2008-07-10 2010-01-14 Nodality, Inc. Methods for diagnosis, prognosis and treatment

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ALESSANDRA CESANO ET AL: "Cell Signaling-Based Classifier Predicts Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia", PLOS ONE, vol. 10, no. 4, 17 April 2015 (2015-04-17), pages e0118485, XP055472119, DOI: 10.1371/journal.pone.0118485 *
DAVID B ROSEN ET AL: "Assessing signaling pathways associated with in vitro resistance to cytotoxic agents in AML", LEUKEMIA RESEARCH, NEW YORK,NY, US, vol. 36, no. 7, 26 February 2012 (2012-02-26), pages 900 - 904, XP028506953, ISSN: 0145-2126, [retrieved on 20120310], DOI: 10.1016/J.LEUKRES.2012.02.022 *
NORMAN J. LACAYO ET AL: "Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group", BRITISH JOURNAL OF HAEMATOLOGY, vol. 162, no. 2, 1 July 2013 (2013-07-01), GB, pages 250 - 262, XP055472110, ISSN: 0007-1048, DOI: 10.1111/bjh.12370 *
S M KORNBLAU: "Supplementary data for XP055097702", 4 June 2010 (2010-06-04), XP055471906, Retrieved from the Internet <URL:www> [retrieved on 20180502] *
S. M. KORNBLAU ET AL: "Dynamic Single-Cell Network Profiles in Acute Myelogenous Leukemia Are Associated with Patient Response to Standard Induction Therapy", CLINICAL CANCER RESEARCH, vol. 16, no. 14, 4 June 2010 (2010-06-04), pages 3721 - 3733, XP055097702, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-10-0093 *
See also references of WO2016036878A1 *

Also Published As

Publication number Publication date
EP3189161A1 (en) 2017-07-12
WO2016036878A1 (en) 2016-03-10

Similar Documents

Publication Publication Date Title
EP3200915A4 (en) Biochars and biochar treatment processes
EP3145875A4 (en) Electrochemical treatment methods
EP3119908A4 (en) Determining cancer aggressiveness, prognosis and responsiveness to treatment
EP3107642A4 (en) Systems and methods for treating blood
EP3110443A4 (en) Combination method for treatment of cancer
EP3238761A4 (en) Blood treatment system
EP3179993A4 (en) Method for the treatment of depression
EP3134436A4 (en) Treatment of h-ras-driven tumors
EP3126814A4 (en) Methods and systems for cancer diagnosis and prognosis
GB201413357D0 (en) Antibodies for treatment and diagnosis
EP3215148A4 (en) Methods for treatment of cognitive decline
EP3095377A4 (en) Endoscope system and endoscope system operation method
EP3123925A4 (en) Endoscope system, processor device of endoscope system, and method for operating endoscope system
EP3236963A4 (en) Method of treatment
EP3110902A4 (en) Well treatment methods and fluids
EP3112798A4 (en) Blast treatment method
EP3127466A4 (en) Endoscope system, processing device of endoscope system, and method for operating endoscope system
EP3092027A4 (en) Transpapillary methods and compositions for diagnosing and treating breast conditions
EP3292218A4 (en) Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer
EP3139922A4 (en) Methods of diagnosing and treating tuberculosis
EP3137129A4 (en) Systems and methods for tissue treatment
EP3137908A4 (en) Methods and compositions for diagnosis and treatment of meningitis
EP3145525A4 (en) Use of microperoxidases for the treatment of carboxyhemoglobinemia
EP3197138A4 (en) Line diagnosis method and apparatus
EP3119282A4 (en) Glucometer and method for use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20170403

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20180522

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/574 20060101ALI20180515BHEP

Ipc: C12Q 1/68 20060101AFI20180515BHEP

Ipc: G01N 33/53 20060101ALI20180515BHEP

Ipc: C12Q 1/37 20060101ALI20180515BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20181219